These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 20005936

  • 1. PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B.
    Jain AK, Goyal AK, Mishra N, Vaidya B, Mangal S, Vyas SP.
    Int J Pharm; 2010 Mar 15; 387(1-2):253-62. PubMed ID: 20005936
    [Abstract] [Full Text] [Related]

  • 2. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B.
    Jain S, Singh P, Mishra V, Vyas SP.
    Immunol Lett; 2005 Oct 15; 101(1):41-9. PubMed ID: 15869802
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B.
    Jain AK, Goyal AK, Gupta PN, Khatri K, Mishra N, Mehta A, Mangal S, Vyas SP.
    J Control Release; 2009 Jun 05; 136(2):161-9. PubMed ID: 19239919
    [Abstract] [Full Text] [Related]

  • 4. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes.
    Shukla A, Katare OP, Singh B, Vyas SP.
    Int J Pharm; 2010 Jan 29; 385(1-2):47-52. PubMed ID: 19835938
    [Abstract] [Full Text] [Related]

  • 5. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
    Jaganathan KS, Vyas SP.
    Vaccine; 2006 May 08; 24(19):4201-11. PubMed ID: 16446012
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
    Wang J, Feng SS, Wang S, Chen ZY.
    Int J Pharm; 2010 Nov 15; 400(1-2):194-200. PubMed ID: 20801205
    [Abstract] [Full Text] [Related]

  • 7. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.
    Ishihara T, Kubota T, Choi T, Takahashi M, Ayano E, Kanazawa H, Higaki M.
    Int J Pharm; 2009 Jun 22; 375(1-2):148-54. PubMed ID: 19481700
    [Abstract] [Full Text] [Related]

  • 8. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.
    Borges O, Cordeiro-da-Silva A, Tavares J, Santarém N, de Sousa A, Borchard G, Junginger HE.
    Eur J Pharm Biopharm; 2008 Jun 22; 69(2):405-16. PubMed ID: 18364251
    [Abstract] [Full Text] [Related]

  • 9. Novel nanoparticles for the delivery of recombinant hepatitis B vaccine.
    Bharali DJ, Pradhan V, Elkin G, Qi W, Hutson A, Mousa SA, Thanavala Y.
    Nanomedicine; 2008 Dec 22; 4(4):311-7. PubMed ID: 18640075
    [Abstract] [Full Text] [Related]

  • 10. Elastic liposomes mediated transcutaneous immunization against Hepatitis B.
    Mishra D, Dubey V, Asthana A, Saraf DK, Jain NK.
    Vaccine; 2006 May 29; 24(22):4847-55. PubMed ID: 16600441
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles.
    Borges O, Tavares J, de Sousa A, Borchard G, Junginger HE, Cordeiro-da-Silva A.
    Eur J Pharm Sci; 2007 Dec 29; 32(4-5):278-90. PubMed ID: 17884394
    [Abstract] [Full Text] [Related]

  • 12. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
    Khatri K, Goyal AK, Gupta PN, Mishra N, Vyas SP.
    Int J Pharm; 2008 Apr 16; 354(1-2):235-41. PubMed ID: 18182259
    [Abstract] [Full Text] [Related]

  • 13. PLA-PEG particles as nasal protein carriers: the influence of the particle size.
    Vila A, Sánchez A, Evora C, Soriano I, McCallion O, Alonso MJ.
    Int J Pharm; 2005 Mar 23; 292(1-2):43-52. PubMed ID: 15725552
    [Abstract] [Full Text] [Related]

  • 14. Chitosan-based nanoparticles for improving immunization against hepatitis B infection.
    Prego C, Paolicelli P, Díaz B, Vicente S, Sánchez A, González-Fernández A, Alonso MJ.
    Vaccine; 2010 Mar 19; 28(14):2607-14. PubMed ID: 20096389
    [Abstract] [Full Text] [Related]

  • 15. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
    Pawar D, Mangal S, Goswami R, Jaganathan KS.
    Eur J Pharm Biopharm; 2013 Nov 19; 85(3 Pt A):550-9. PubMed ID: 23831265
    [Abstract] [Full Text] [Related]

  • 16. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.
    Mishra D, Mishra PK, Dubey V, Nahar M, Dabadghao S, Jain NK.
    Eur J Pharm Sci; 2008 Apr 23; 33(4-5):424-33. PubMed ID: 18359615
    [Abstract] [Full Text] [Related]

  • 17. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S, Poulin S, Hildgen P.
    J Biomed Mater Res A; 2008 Dec 15; 87(4):885-95. PubMed ID: 18228249
    [Abstract] [Full Text] [Related]

  • 18. PEG-PLA diblock copolymer micelle-like nanoparticles as all-trans-retinoic acid carrier: in vitro and in vivo characterizations.
    Li Y, Qi XR, Maitani Y, Nagai T.
    Nanotechnology; 2009 Feb 04; 20(5):055106. PubMed ID: 19417337
    [Abstract] [Full Text] [Related]

  • 19. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.
    Feng L, Qi XR, Zhou XJ, Maitani Y, Wang SC, Jiang Y, Nagai T.
    J Control Release; 2006 May 01; 112(1):35-42. PubMed ID: 16516999
    [Abstract] [Full Text] [Related]

  • 20. Cationic transfersomes based topical genetic vaccine against hepatitis B.
    Mahor S, Rawat A, Dubey PK, Gupta PN, Khatri K, Goyal AK, Vyas SP.
    Int J Pharm; 2007 Aug 01; 340(1-2):13-9. PubMed ID: 17446015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.